ATE317689T1 - Schnelllösliche tabletten - Google Patents

Schnelllösliche tabletten

Info

Publication number
ATE317689T1
ATE317689T1 AT01990823T AT01990823T ATE317689T1 AT E317689 T1 ATE317689 T1 AT E317689T1 AT 01990823 T AT01990823 T AT 01990823T AT 01990823 T AT01990823 T AT 01990823T AT E317689 T1 ATE317689 T1 AT E317689T1
Authority
AT
Austria
Prior art keywords
tablets
dissolving tablets
mouth
quick dissolving
processes
Prior art date
Application number
AT01990823T
Other languages
English (en)
Inventor
Khawla A Abu-Izza
Vincent H Li
Jee L Look
Graham D Parr
Matthew K Schineller
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE317689T1 publication Critical patent/ATE317689T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01990823T 2000-12-06 2001-12-04 Schnelllösliche tabletten ATE317689T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/731,479 US6733781B2 (en) 2000-12-06 2000-12-06 Fast dissolving tablet

Publications (1)

Publication Number Publication Date
ATE317689T1 true ATE317689T1 (de) 2006-03-15

Family

ID=24939673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01990823T ATE317689T1 (de) 2000-12-06 2001-12-04 Schnelllösliche tabletten

Country Status (10)

Country Link
US (1) US6733781B2 (de)
EP (1) EP1365743B1 (de)
AT (1) ATE317689T1 (de)
AU (2) AU2002230589B2 (de)
CA (1) CA2436287C (de)
DE (1) DE60117289D1 (de)
MX (1) MXPA03005098A (de)
NZ (1) NZ526368A (de)
WO (1) WO2002045571A2 (de)
ZA (1) ZA200304511B (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
EP1175205B1 (de) * 1999-11-12 2006-06-14 Abbott Laboratories Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
US20030165566A1 (en) * 2002-01-10 2003-09-04 O'toole Edel Sedative non-benzodiazepine formulations
JP3368898B1 (ja) * 2002-01-24 2003-01-20 味の素株式会社 分岐鎖アミノ酸含有顆粒の製造方法
SE0200539D0 (sv) * 2002-02-25 2002-02-25 Metcon Medicin Ab Granulation process and starch granulate
US20050147670A1 (en) * 2002-05-29 2005-07-07 Impax Laboratories Inc. Oral disintegrating dosage forms
BR0313175A (pt) * 2002-08-02 2005-06-14 Boehringer Ingelheim Int Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
ATE544354T1 (de) 2002-11-26 2012-02-15 Univ Chicago Vermeidung und behandlung von mikrobenübertragenen epithelerkrankungen
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8012505B2 (en) * 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
CA2516291C (en) * 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
DE20305898U1 (de) 2003-04-03 2003-07-31 Orantek, Katharina, 60488 Frankfurt Vitaminhaltige Arzneizubereitung
JP2005053853A (ja) * 2003-08-06 2005-03-03 Shikoku Chem Corp 発泡性塩素化イソシアヌル酸成形物
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
KR20070030178A (ko) * 2004-02-17 2007-03-15 트랜스오랄 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의사용 방법
WO2006018954A1 (ja) * 2004-08-17 2006-02-23 Eisai R & D Management Co., Ltd. ジブロモフルオロベンゼン誘導体の製造方法
WO2006105615A1 (en) * 2005-04-08 2006-10-12 Ozpharma Pty Ltd Buccal delivery system
US9028882B2 (en) 2005-05-02 2015-05-12 4Life Patents, Llc Nutraceutical gels
ES2659538T3 (es) 2005-05-02 2018-03-16 4Life Patents, Llc Preparaciones de factor de transferencia y métodos asociados
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
BRPI0609984A2 (pt) * 2005-05-25 2010-05-18 Transcept Pharmaceuticals Inc uso de zolpidem ou um sal do mesmo
US20070020186A1 (en) * 2005-07-22 2007-01-25 Alpex Pharma S.A. Solid dosage formulations of narcotic drugs having improved buccal adsorption
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20070243248A1 (en) * 2006-04-14 2007-10-18 Cherukuri S Rao Rapidly disintegrating solid oral dosage form of liquid dispersions
US20070251352A1 (en) 2006-05-01 2007-11-01 Pruitt Judith G Pelletized Feed Material for Biomass Generator
EP2043613A1 (de) * 2006-07-14 2009-04-08 Fmc Corporation Feste form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
US7979151B2 (en) * 2007-12-06 2011-07-12 International Business Machines Corporation Run-time dispatch system for enhanced product characterization capability
EP2331047A4 (de) * 2008-08-29 2013-10-30 Schulman A Inc Optimierte aromatisierte polymerzusammensetzungen
US20100075930A1 (en) * 2008-09-03 2010-03-25 Yoel Ovil Salicylic salt compositions and related method of treatment of cardiac conditions
WO2010077878A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
CN102438597A (zh) 2009-03-09 2012-05-02 丁内沙·沙蒂尔阿尔·帕特尔 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂
EP2440210A4 (de) * 2009-06-12 2014-01-29 Meritage Pharma Inc Verfahren zur behandlung von magen-darm-erkrankungen
US8551762B2 (en) 2009-07-07 2013-10-08 Nch Corporation System and apparatus for feeding, solubilizing, growing and discharging a biological material
US8961893B2 (en) * 2009-07-07 2015-02-24 Nch Corporation Automated chemical diluter system having disposable components
EP2314296A1 (de) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Im Mund zerfallende Betahistin Tabletten
DE102011010437A1 (de) * 2011-02-04 2012-08-09 J. Rettenmaier & Söhne Gmbh + Co. Kg Tablettierhilfsmittel
DE102013004263A1 (de) 2013-03-13 2014-09-18 Martin Lipsdorf Schnell lösliche orale Darreichungsform und Methode zur Herstellung derselben
CN105658211A (zh) 2013-10-07 2016-06-08 怡百克制药公司 左旋多巴和/或左旋多巴的酯的粘膜粘附性、控制释放调配物和其用途
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
WO2017080566A1 (en) * 2015-11-09 2017-05-18 Rontis Hellas S.A. Stable analgesic pharmaceutical composition and process for the preparation thereof
US10323226B2 (en) 2017-03-30 2019-06-18 Nch Corporation Feed material for biomass generator
CH714189A1 (de) * 2017-09-25 2019-03-29 Omanda Ag Verfahren zur Herstellung von L-Leucin und Molkenprotein L-Leucin zur Nahrungsanreicherung und dessen Anwendung.
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen
US12194150B2 (en) 2020-12-22 2025-01-14 Amneal Pharmaceuticals Llc Levodopa dosing regimen
CN119424454B (zh) * 2024-11-06 2025-08-08 广东万泰科创药业有限公司 一种药物复合包装制剂及其制备方法和应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0345628B1 (de) 1988-06-07 1993-05-12 Abbott Laboratories Feste Arzneidosis in Form eines Tablettentriturats sowie Verfahren zu deren Herstellung
CH675819A5 (de) 1988-06-10 1990-11-15 Nestle Sa
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
EP0737473A1 (de) 1989-10-02 1996-10-16 Cima Labs, Inc. Brausedosisform
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
CA2117351C (en) 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
EP0627218B1 (de) * 1992-02-18 2001-12-19 Nippon Shinyaku Company, Limited Verfahren zur Herstellung von schnelllöslicher Tabletten und schnelllöslichen Tablette beinhaltend Xylitol
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
JPH1135451A (ja) 1994-07-27 1999-02-09 Yamanouchi Pharmaceut Co Ltd 口腔内溶解型錠剤およびその製造方法
US5609883A (en) 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5728403A (en) * 1994-10-05 1998-03-17 The Board Of Regents Of The University Of Nebraska Coating technology for taste masking orally administered bitter drugs
US5807578A (en) 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807577A (en) 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5762961A (en) 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
WO1997038679A2 (en) 1996-04-16 1997-10-23 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US5837292A (en) 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
RU2189227C2 (ru) 1996-07-12 2002-09-20 Дайити Фармасьютикал Ко., Лтд. Быстро распадающиеся прессованные в формах материалы и способ их получения
GB9619074D0 (en) 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US5939091A (en) 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
EP1058538B9 (de) 1998-03-06 2013-01-02 Aptalis Pharma S.r.l. Schnell zerfallende tablette
NL1008716C2 (nl) 1998-03-26 1999-09-28 Pharmachemie Bv Farmaceutisch preparaat.
GT199900061A (es) 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.

Also Published As

Publication number Publication date
WO2002045571A2 (en) 2002-06-13
DE60117289D1 (de) 2006-04-20
US6733781B2 (en) 2004-05-11
MXPA03005098A (es) 2004-02-12
WO2002045571A3 (en) 2002-08-29
HK1059217A1 (en) 2004-06-25
US20020114833A1 (en) 2002-08-22
ZA200304511B (en) 2004-03-05
CA2436287C (en) 2010-08-03
CA2436287A1 (en) 2002-06-13
AU3058902A (en) 2002-06-18
NZ526368A (en) 2004-03-26
EP1365743B1 (de) 2006-02-15
AU2002230589B2 (en) 2005-11-10
EP1365743A2 (de) 2003-12-03

Similar Documents

Publication Publication Date Title
DE60117289D1 (de) Schnelllösliche tabletten
SE0001899D0 (sv) New compounds
AU7001001A (en) Modified forms of pharmacologically active agents and uses therefor
DK1157037T3 (da) GCSF-konjugater
BR9911160A (pt) Ciclosporinas
SE0300010D0 (sv) Novel Compounds
BG106013A (en) New compounds and compositions as protease inhibitors
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
ATE364595T1 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
HUP0401811A2 (hu) Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására
TW200502231A (en) Prodrugs of proton pump inhibitors
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
ATE248832T1 (de) Antagonisten des gonadotropin freisetzenden hormons
DE502005010427D1 (de) Physiologisch aktive zusammensetzung gegen diabetes
DK1283845T3 (da) Fremgangsmåde til fremstilling af farmaceutiske acceptable salte af (SS-RS)-S-adenosyl-L-methionin
WO2002098850A3 (en) Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
DE60120120D1 (de) Beutelformzusammensetzungen
BR0202204A (pt) Formulações estabilizadas
PT1292303E (pt) Formulacao farmaceutica estavel compreendendo modificacao de torsemida ii

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties